• Psyched Wellness (PSYC) is reporting a recent positive study into its lead compound
  • KGK, a licensed Contract research organization in Canada, has completed the last study on the safety and efficacy of Amanita Muscaria extract (AME-1) extract
  • The result of the study shows that AME-1 alone or in combination with ethanol did not impair any learning or memory state, motor coordination, balance, or altered behavioural activity
  • Psyched Wellness (PSYC) opened trading at C$0.06 per share

Psyched Wellness (PSYC) is reporting a recent positive study into its lead compound.

KGK, a licensed Contract research organization in Canada, has completed the last study on the safety and efficacy of Amanita Muscaria extract (AME-1) extract.

The neurobehavioral study was to evaluate the efficacy and safety of AME-1 alone, and in combination with behavioral tests. All of the tests were designed to look at behavioural despair, memory, and learning, motor coordination, and maintaining balance.

The result of the study shows that AME-1 alone or in combination with ethanol did not impair any learning or memory state, motor coordination, balance, or altered behavioural activity.

Brian Tancowny, a scientific advisor for Psyched Wellness, stated that this further provides information in the toxicological assessment of AME-1.

“The results of this study further increases the knowledge in a scientific setting indicating no negative behavioural and neurological functional changes with the use of AME-1.”

Psyched Wellness is a Canadian health supplements company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom.

Psyched Wellness (PSYC) opened trading at C$0.06 per share.

More From The Market Online

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

GameStop stock struggles on weak Q4 2023 performance

GameStop Corp. (NYSE:GME) stock struggles after reporting weak Q4 2023 financial results, but it eventually claws back some gains.

Air Canada builds on robust 2023 with APEX award

Air Canada (TSX:AC) receives the 2024 APEX Best in Entertainment Award in North America at Tuesday night's ceremony in Lisbon.

Bombardier’s new record-setting 7500 jet lands in Asia

Bombardier’s (TSX:BBD.A) new Global 7500 business aircraft has been touring Asia this week with stops in Hong Kong, Beijing and Seoul.